LAFSX | VIVIX | LAFSX / VIVIX | |
Total Expense Ratio | 0.69 | 0.04 | 1,725% |
Annual Report Gross Expense Ratio | 0.69 | 0.04 | 1,725% |
Fund Existence | 10 years | 27 years | - |
Gain YTD | 7.601 | 6.215 | 122% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.22B | 189B | 3% |
Annual Yield % from dividends | 1.46 | 2.19 | 67% |
Returns for 1 year | 10.36 | 12.05 | 86% |
Returns for 3 years | 32.52 | 35.17 | 92% |
Returns for 5 years | 61.97 | 80.14 | 77% |
Returns for 10 years | 41.06 | 115.68 | 35% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
DBMAX | 28.85 | 0.28 | +0.98% |
BNY Mellon Sm/Md Cp Gr A | |||
VLACX | 116.61 | 1.01 | +0.87% |
Vanguard Large Cap Index Investor | |||
GVIRX | 17.76 | 0.10 | +0.57% |
Goldman Sachs US Eq Div and Premium Inv | |||
JMNCX | 13.06 | 0.02 | +0.15% |
JPMorgan Research Market Neutral C | |||
EVDIX | 21.57 | -0.04 | -0.19% |
Camelot Event Driven Institutional |